AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics
Leukemia
.
2022 Jul;36(7):1939-1942.
doi: 10.1038/s41375-022-01631-z.
Epub 2022 Jun 20.
Authors
Irene Fuhrmann
#
1
,
Miriam Lenk
#
1
,
Torsten Haferlach
1
,
Anna Stengel
1
,
Stephan Hutter
1
,
Constance Baer
1
,
Manja Meggendorfer
1
,
Wolfgang Kern
1
,
Claudia Haferlach
2
Affiliations
1
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.
2
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany. claudia.haferlach@mll.com.
#
Contributed equally.
PMID:
35725772
PMCID:
PMC9252909
DOI:
10.1038/s41375-022-01631-z
No abstract available
Publication types
Letter
MeSH terms
Cytogenetic Analysis
Humans
Leukemia, Myeloid, Acute* / genetics
Mutation
Myelodysplastic Syndromes* / genetics
Prognosis